Continuity of supply is absolute paramount to get market recognition. A2 management need to hit the ground sprinting with this.
Margins will be lower but its all out volume. This type is the news is what long term shareholders have been waiting for. I wish management every success on the execution of this opportunity.
Ann: FDA approval to supply infant milk formula to United States, page-25
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.92 |
Change
0.070(1.02%) |
Mkt cap ! $5.002B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $6.94 | $6.89 | $1.402M | 202.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 7070 | $6.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.92 | 2151 | 10 |
View Market Depth
| Last trade - 12.51pm 29/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |